Literature DB >> 33597297

Astrocytes lure CXCR2-expressing CD4+ T cells to gray matter via TAK1-mediated chemokine production in a mouse model of multiple sclerosis.

Yee Ming Khaw1,2, Abbey Tierney1,3, Claire Cunningham1,3, Katiria Soto-Díaz2,4,5, Eunjoo Kang1,2, Andrew J Steelman2,4,5, Makoto Inoue6,2.   

Abstract

Multiple sclerosis (MS) is a chronic neurological disease of the central nervous system driven by peripheral immune cell infiltration and glial activation. The pathological hallmark of MS is demyelination, and mounting evidence suggests neuronal damage in gray matter is a major contributor to disease irreversibility. While T cells are found in both gray and white matter of MS tissue, they are typically confined to the white matter of the most commonly used mouse model of MS, experimental autoimmune encephalomyelitis (EAE). Here, we used a modified EAE mouse model (Type-B EAE) that displays severe neuronal damage to investigate the interplay between peripheral immune cells and glial cells in the event of neuronal damage. We show that CD4+ T cells migrate to the spinal cord gray matter, preferentially to ventral horns. Compared to CD4+ T cells in white matter, gray matter-infiltrated CD4+ T cells were mostly immobilized and interacted with neurons, which are behaviors associated with detrimental effects to normal neuronal function. T cell-specific deletion of CXCR2 significantly decreased CD4+ T cell infiltration into gray matter in Type-B EAE mice. Further, astrocyte-targeted deletion of TAK1 inhibited production of CXCR2 ligands such as CXCL1 in gray matter, successfully prevented T cell migration into spinal cord gray matter, and averted neuronal damage and motor dysfunction in Type-B EAE mice. This study identifies astrocyte chemokine production as a requisite for the invasion of CD4+T cell into the gray matter to induce neuronal damage.

Entities:  

Keywords:  T cell migration; astrocyte; dendritic spine loss; gray matter; multiple sclerosis

Mesh:

Substances:

Year:  2021        PMID: 33597297      PMCID: PMC7923593          DOI: 10.1073/pnas.2017213118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  68 in total

Review 1.  Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.

Authors:  C Bjartmar; J R Wujek; B D Trapp
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

Review 2.  Molecular mechanisms involved in T cell migration across the blood-brain barrier.

Authors:  B Engelhardt
Journal:  J Neural Transm (Vienna)       Date:  2006-04       Impact factor: 3.575

3.  Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.

Authors:  Bruce D Trapp; Megan Vignos; Jessica Dudman; Ansi Chang; Elizabeth Fisher; Susan M Staugaitis; Harsha Battapady; Sverre Mork; Daniel Ontaneda; Stephen E Jones; Robert J Fox; Jacqueline Chen; Kunio Nakamura; Richard A Rudick
Journal:  Lancet Neurol       Date:  2018-08-22       Impact factor: 44.182

4.  TrackMate: An open and extensible platform for single-particle tracking.

Authors:  Jean-Yves Tinevez; Nick Perry; Johannes Schindelin; Genevieve M Hoopes; Gregory D Reynolds; Emmanuel Laplantine; Sebastian Y Bednarek; Spencer L Shorte; Kevin W Eliceiri
Journal:  Methods       Date:  2016-10-03       Impact factor: 3.608

Review 5.  Progressive multiple sclerosis and gray matter pathology: an MRI perspective.

Authors:  Matilde Inglese; Niels Oesingmann; Patrizia Casaccia; Lazar Fleysher
Journal:  Mt Sinai J Med       Date:  2011 Mar-Apr

6.  Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.

Authors:  Sarah E Lutz; Julian R Smith; Dae Hwan Kim; Carl V L Olson; Kyle Ellefsen; Jennifer M Bates; Sunil P Gandhi; Dritan Agalliu
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

7.  Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.

Authors:  Laurence Jasse; Sandra Vukusic; Françoise Durand-Dubief; Cristina Vartin; Carolina Piras; Martine Bernard; Denis Pélisson; Christian Confavreux; Alain Vighetto; Caroline Tilikete
Journal:  Mult Scler       Date:  2013-03-05       Impact factor: 6.312

8.  Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals.

Authors:  Tobias Derfuss; Khyati Parikh; Sviataslau Velhin; Magdalena Braun; Emily Mathey; Markus Krumbholz; Tania Kümpfel; Anja Moldenhauer; Christoph Rader; Peter Sonderegger; Walter Pöllmann; Christian Tiefenthaller; Jan Bauer; Hans Lassmann; Hartmut Wekerle; Domna Karagogeos; Reinhard Hohlfeld; Christopher Linington; Edgar Meinl
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

Review 9.  Progressive multiple sclerosis: pathology and pathogenesis.

Authors:  Hans Lassmann; Jack van Horssen; Don Mahad
Journal:  Nat Rev Neurol       Date:  2012-09-25       Impact factor: 42.937

10.  Resolving and Rescuing Developmental Miswiring in a Mouse Model of Cognitive Impairment.

Authors:  Mattia Chini; Jastyn A Pöpplau; Christoph Lindemann; Laura Carol-Perdiguer; Marilena Hnida; Victoria Oberländer; Xiaxia Xu; Joachim Ahlbeck; Sebastian H Bitzenhofer; Christoph Mulert; Ileana L Hanganu-Opatz
Journal:  Neuron       Date:  2019-11-13       Impact factor: 17.173

View more
  4 in total

Review 1.  Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function.

Authors:  Alanna G Spiteri; Claire L Wishart; Roger Pamphlett; Giuseppe Locatelli; Nicholas J C King
Journal:  Acta Neuropathol       Date:  2021-12-01       Impact factor: 17.088

2.  NAD+ metabolism drives astrocyte proinflammatory reprogramming in central nervous system autoimmunity.

Authors:  Tom Meyer; Dor Shimon; Sawsan Youssef; Gal Yankovitz; Adi Tessler; Tom Chernobylsky; Anat Gaoni-Yogev; Rita Perelroizen; Noga Budick-Harmelin; Lawrence Steinman; Lior Mayo
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-22       Impact factor: 12.779

3.  Reduced CXCL1 production by endogenous IL-37 expressing dendritic cells does not affect T cell activation.

Authors:  M Kouwenberg; W P C Pulskens; L Diepeveen; M Bakker-van Bebber; C A Dinarello; M G Netea; L B Hilbrands; J van der Vlag
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

Review 4.  Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination.

Authors:  Martin Zirngibl; Peggy Assinck; Anastasia Sizov; Andrew V Caprariello; Jason R Plemel
Journal:  Mol Neurodegener       Date:  2022-05-07       Impact factor: 18.879

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.